Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11346336 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma
Condition: Cutaneous T-Cell Lymphoma
Interventions: Drug: bexarotene;   Device: photopheresis

Indicates status has not been verified in more than two years